Labcorp — Q3 2026 Earnings Summary

Labcorp Holdings Inc. reported strong third-quarter 2026 results with revenue reaching $3.81 billion, representing a 6.9% increase from the prior year period. The company achieved diluted earnings per share of $3.22 and adjusted earnings per share of $4.78, reflecting a 14.5% year-over-year growth in adjusted metrics. In response to this performance, Labcorp raised its full-year 2026 enterprise revenue growth guidance to a range of 5.9% to 6.7% and adjusted EPS guidance to $18.30 to $18.70. Strategic initiatives during the quarter included the FDA approval of a companion diagnostic for advanced melanoma and the announcement of four new acquisitions expected to be accretive to earnings.